Bar Harbor Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$477K Buy
3,042
+50
+2% +$7.5K 0.03% 185
2026
Q1
$457K Buy
2,992
+79
+3% +$12.1K 0.03% 190
2025
Q4
$402K Sell
2,913
-150
-5% -$19.6K 0.02% 199
2025
Q3
$393K Hold
3,063
0.02% 202
2025
Q2
$371K Sell
3,063
-300
-9% -$33.8K 0.02% 198
2025
Q1
$375K Buy
3,363
+230
+7% +$24.5K 0.02% 196
2024
Q4
$305K Sell
3,133
-536
-15% -$57.2K 0.02% 211
2024
Q3
$422K Sell
3,669
-350
-9% -$39.7K 0.03% 199
2024
Q2
$428K Sell
4,019
-4
-0.1% -$402 0.03% 191
2024
Q1
$389K Buy
4,023
+503
+14% +$51.6K 0.03% 201
2023
Q4
$355K Buy
3,520
+313
+10% +$30.2K 0.03% 201
2023
Q3
$327K Hold
3,207
0.03% 203
2023
Q2
$324K Sell
3,207
-100
-3% -$10K 0.02% 210
2023
Q1
$304K Hold
3,307
0.02% 212
2022
Q4
$300K Buy
3,307
+71
+2% +$5.98K 0.02% 221
2022
Q3
$246K Buy
3,236
+49
+2% +$4.06K 0.02% 225
2022
Q2
$269K Buy
+3,187
New +$280K 0.02% 231
2022
Q1
Sell
-2,986
Closed -$262K 250
2021
Q4
$262K Sell
2,986
-100
-3% -$8.3K 0.02% 206
2021
Q3
$253K Sell
3,086
-192
-6% -$17.3K 0.02% 210
2021
Q2
$300K Sell
3,278
-167
-5% -$14.9K 0.03% 200
2021
Q1
$294K Sell
3,445
-70
-2% -$6.28K 0.03% 201
2020
Q4
$332K Sell
3,515
-748
-18% -$65.4K 0.03% 191
2020
Q3
$371K Sell
4,263
-3,475
-45% -$301K 0.04% 172
2020
Q2
$676K Sell
7,738
-842
-10% -$72.7K 0.08% 128
2020
Q1
$707K Sell
8,580
-1,472
-15% -$131K 0.1% 130
2019
Q4
$952K Sell
10,052
-778
-7% -$69.8K 0.1% 136
2019
Q3
$941K Sell
10,830
-274
-2% -$24.6K 0.11% 148
2019
Q2
$1.01M Sell
11,104
-1,120
-9% -$94.8K 0.12% 140
2019
Q1
$1.05M Sell
12,224
-446
-4% -$35.8K 0.13% 129
2018
Q4
$974K Sell
12,670
-508
-4% -$39.5K 0.13% 132
2018
Q3
$1.02M Sell
13,178
-355
-3% -$26.2K 0.12% 145
2018
Q2
$916K Sell
13,533
-1,649
-11% -$114K 0.11% 142
2018
Q1
$1.1M Sell
15,182
-2,672
-15% -$203K 0.13% 129
2017
Q4
$1.34M Sell
17,854
-2,202
-11% -$166K 0.16% 118
2017
Q3
$1.54M Sell
20,056
-2,409
-11% -$182K 0.19% 106
2017
Q2
$1.68M Sell
22,465
-3,591
-14% -$255K 0.2% 103
2017
Q1
$1.73M Sell
26,056
-5,914
-18% -$394K 0.2% 103
2016
Q4
$2.09M Sell
31,970
-1,596
-5% -$104K 0.23% 89
2016
Q3
$2.38M Sell
33,566
-195
-0.6% -$14.2K 0.27% 79
2016
Q2
$2.5M Buy
33,761
+293
+0.9% +$20.2K 0.29% 76
2016
Q1
$2.17M Sell
33,468
-426
-1% -$29K 0.27% 80
2015
Q4
$2.61M Sell
33,894
-3,003
-8% -$239K 0.33% 68
2015
Q3
$3.04M Sell
36,897
-710
-2% -$63.2K 0.4% 62
2015
Q2
$3.31M Buy
37,607
+89
+0.2% +$8.16K 0.4% 63
2015
Q1
$3.31M Buy
37,518
+1,415
+4% +$126K 0.4% 65
2014
Q4
$3M Buy
36,103
+173
+0.5% +$14.3K 0.37% 65
2014
Q3
$3.03M Sell
35,930
-1,350
-4% -$109K 0.39% 68
2014
Q2
$3.02M Sell
37,280
-127
-0.3% -$9.99K 0.38% 67
2014
Q1
$2.85M Sell
37,407
-1,011
-3% -$73.7K 0.37% 67
2013
Q4
$2.77M Sell
38,418
-356
-0.9% -$24.7K 0.36% 70
2013
Q3
$2.67M Sell
38,774
-251
-0.6% -$16.6K 0.37% 67
2013
Q2
$2.47M Buy
+39,025
New +$2.54M 0.36% 68

Other funds holding NVS

Bar Harbor Wealth Management's NVS Position: Q2 2026 in Review

Bar Harbor Wealth Management increased its Novartis (NVS) stake by 1.7% in Q2 2026, buying an estimated $7.5K and bringing the position to 3,042 shares worth $477K. The position accounts for 0.03% of the portfolio, ranked #185.

Bar Harbor Wealth Management first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.31M in Q1 2015. 285 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Bar Harbor Wealth Management held 3,042 shares of Novartis worth $477K as of Q2 2026.
  • Bar Harbor Wealth Management bought 50 Novartis shares in Q2 2026, an estimated $7.5K.
  • Novartis made up 0.03% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #185 holding.
  • Bar Harbor Wealth Management first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Bar Harbor Wealth Management's Novartis position peaked at $3.31M in Q1 2015.
  • 285 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.